STOCK OPTIONS AND RESTRICTED STOCK UNITS |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STOCK OPTIONS AND RESTRICTED STOCK UNITS |
During the six months ended June 30, 2026, following the sale of Save Foods Ltd., a former subsidiary of the Company, certain options previously granted to employees of Save Foods Ltd. were forfeited in accordance with the terms of the applicable awards.
The aggregate intrinsic value of the awards outstanding as of June 30, 2026 was $. These amounts represent the total intrinsic value, based on the Company’s stock price of $ as of June 30, 2026, less the weighted exercise price.
On October 20, 2025, the Company granted restricted stock units (“RSUs”) to Mr. Alon Silberman under the Company’s 2022 Share Incentive Plan. The RSUs vest in three equal annual installments on each of the first, second and third anniversaries of the grant date, subject to continued employment with MitoCareX.
Costs incurred in respect of stock-options and RSUs compensation for employees and directors for the six and three months ended June 30, 2026 were $ and $, respectively.
NEXENTIS TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (unaudited) (USD in thousands, except share and per share data)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||